2020
DOI: 10.1038/s41598-020-71264-8
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial proteomic profile in pulmonary arterial hypertension

Abstract: Pulmonary arterial hypertension (PAH) is a rare, fatal, and incurable disorder. Although advances in the understanding of the PAH pathobiology have been seen in recent years, molecular processes underlying heart remodelling over the course of PAH are still insufficiently understood. Therefore, the aim of this study was to investigate myocardial proteomic profile of rats at different stages of monocrotaline-induced PAH. Samples of left and right ventricle (LV and RV) free wall collected from 32 Wistar rats were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
19
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(22 citation statements)
references
References 56 publications
3
19
0
Order By: Relevance
“…Proteomic characterization of the hypercholesterolemic myocardium in the current study revealed modest quantitative changes in a substantial number of proteins, which is in accordance with other proteomics-based studies of the left ventricle with impaired contractile function [23,24]. One of the most notable changes in the level of an individual protein was observed in the case of the downregulated expression of ACTB, an essential component of the non-contractile cytoskeleton system.…”
Section: Discussionsupporting
confidence: 90%
“…Proteomic characterization of the hypercholesterolemic myocardium in the current study revealed modest quantitative changes in a substantial number of proteins, which is in accordance with other proteomics-based studies of the left ventricle with impaired contractile function [23,24]. One of the most notable changes in the level of an individual protein was observed in the case of the downregulated expression of ACTB, an essential component of the non-contractile cytoskeleton system.…”
Section: Discussionsupporting
confidence: 90%
“…Additionally, miR-34 has been seen to have decreased expression in PAH [46,47], and let-7d, which has been identified as a potential biomarker for the presence and severity of PH in patients with SSc [48]. Similarly, the target genes driving the classification in an independent RNAseq dataset, TCF7L2, which ranked highest in importance has previously been seen to be differentially expressed in the lung tissue of IPAH patients [49] as well as in the cardiac muscle tissue in a rat model [50] Some of these target genes also showed weak to moderate correlation with available clinical features, such as lung function forced vital capacity (Supplementary Table 10).…”
Section: Discussionmentioning
confidence: 92%
“…Besides, the significant overexpression of RPS27A could enhance the chemoresistance of CML cells to imatinib by trans-activating STAT3 ( Wang et al, 2016 ). However, several studies have identified considerable upregulation of RPS27A expression in the left ventricular myocardium of rats suffering from end-stage PAH (MCT-induced PAH rat model), and abnormal expression of RPS27A has been detected in the peripheral blood of patients with connective tissue disease-associated PAH, and its key regulatory role in the pathogenesis of PAH has been identified ( Hołda et al, 2020 ; Tu et al, 2022 ). Altogether, these findings confirmed that the blood-derived hub transcriptomes are associated with infiltrations of immune cells, hypoxia, and metabolism (glycolysis and fatty acid), which in turn regulates the aberrant vascular remodeling in PAH.…”
Section: Discussionmentioning
confidence: 99%